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Abstract
Background:  Ubiquitin regulates a myriad of important cellular processes through covalent
attachment to its substrates. A classic role for ubiquitin is to flag proteins for destruction by the
proteasome. Recent studies indicate that ubiquitin-binding proteins (e.g. Rad23, Dsk2, Rpn10) play
a pivotal role in transferring ubiquitylated proteins to the proteasome. However, the specific role
of these ubiquitin receptors remains poorly defined. A key to unraveling the functions of these
ubiquitin receptors is to identify their cellular substrates and biological circuits they are involved in.
Although many strategies have been developed for substrate isolation, the identification of
physiological targets of proteolytic pathways has proven to be quite challenging.
Results: Using a genome-wide functional screen, we have identified 11 yeast genes that cause
slower growth upon their overexpression in cells lacking two ubiquitin-binding proteins Rad23 and
Dsk2. Our results suggest that proper functioning of Rad23 and Dsk2 is required for efficient
pheromone response, transcription, amino acid metabolism, and DNA damage response. Two
proteins identified by the screen are shown to be proteolytic substrates of Dsk2, validating the
large scale synthetic dosage lethality screen as a new strategy for identifying substrates of a specific
degradation pathway.
Conclusion: In conclusion, as proof-of-concept, we show that a synthetic dosage lethality screen,
which is based on the toxicity induced by gene overexpression, offers an effective, complementary
method to elucidating biological functions of proteolytic pathways.
Background
In eukaryotes, the 26S proteasome handles the majority of
regulated proteolysis and is pivotal for the proper func-
tion of the cell [1,2]. Most proteins that are targeted to the
proteasome for degradation are first modified by the
ubiquitin (Ub) system [3]. Specifically, successive Ub
molecules join to form a Ub chain on the substrates. How
the ubiquitylated substrate is then delivered to and
degraded by the 26S proteasome remains elusive [2,4-6].
It is now widely accepted that Ub-binding proteins (e.g.
Rad23, Rpn10, and Cdc48) play important roles in facili-
tating substrate transfer to the proteasome. These proteins
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have distinct substrate specificity and functionally cooper-
ate for substrate proteolysis [7-9]. However, how any one
of these proteins works in vivo remains largely unknown
[2,6].
Rad23 belongs to a family of proteins that contain both
the Ub-associated (UBA) domain and a Ub-like (UBL)
motif [2,4-6]. The UBA motif binds specifically to Ub
chain/conjugates in vivo and  in vitro [10-12]. The UBL
motif directly binds the proteasome [13,14]. Through
these domain-mediated interactions, UBA/UBL proteins
link ubiquitylated proteins to the proteasome. In the bud-
ding yeast Saccharomyces cerevisiae, there are three UBA/
UBL-containing proteins, Rad23, Dsk2 and Ddi1, which
have been implicated in Ub-mediated proteolysis. The
loss of S. cerevisiae Rad23 and Dsk2 leads to the stabiliza-
tion of an artificially designed Ub-fusion substrate UbV76-
V-βgal [12,15], the cell cycle inhibitor Far1 [7], misfolded
protein CPY* [16], an ER protein Hmg2 [8], and the
homologues of Rad23 are involved in the degradation of
the CDK inhibitor Rum1 [11], Pax3 [17] and the tumor
suppressor p53 [18]. Consistent with the role of Rad23
and Dsk2 in post-ubiquitylation events, the stabilized
substrates in rad23Δ dsk2Δ mutant cells are fully ubiquit-
ylated. Rad23 and Dsk2 play overlapping functions since
cells lacking both RAD23 and DSK2 are more sensitive to
various stress conditions (e.g., higher temperature, cana-
vanine, high salt) than either single mutant [19,20]. How-
ever, the biological pathways that require the functioning
of Rad23 and Dsk2 remain to be identified.
Not all proteolytic substrates are degraded by the Rad23/
Dsk2-dependent pathway. Other Ub-binding proteins,
Rpn10, Rpn13, and the Cdc48-Ufd1-Npl4 complex also
promote proteasome-mediated proteolysis and exhibit
distinct substrate specificity [5,7-9,21]. For example, the
cell cycle protein Clb2 requires Rpn10, but not Rad23 for
its degradation. And Deg1-GFP is degraded by the Cdc48/
Ufd1 pathway, independent of Rpn10 and Rad23. The
principle underlying the division of labor among these
Ub-binding proteins is far from clear. A key to unraveling
the functions of these Ub receptors (e.g. Rad23, Rpn10) is
to identify their cellular substrates and biological func-
tions. For example, using mass spectrometry, more than
50 proteins were shown to be preferentially accumulated
in cells lacking RPN10 [22,23]. These putative Rpn10 sub-
strates are involved in cell cycle control, protein transport,
metabolism, and transcription.
Here, we employ a new method to identify the biological
function of Rad23 and Dsk2. The lack of overt phenotypes
in rad23Δ dsk2Δ mutant cells likely reflects that redundant
pathways are employed in buffering against mutations.
Using a synthetic enhancement approach, we have iso-
lated 11 genes that when overexpressed cause slow growth
in rad23Δ dsk2Δ mutants. Our data expand the physiolog-
ical processes that involve Rad23 and Dsk2. Furthermore,
we show that two of the encoded proteins isolated by this
method are ubiquitylated and degraded by the Dsk2-
dependent pathway. Our results also suggest that the syn-
thetic dosage lethality screen can be used to isolate physi-
ological targets of a specific proteolytic pathway.
Methods
Strains, media and plasmids
Yeast cultures were grown in rich (YPD) or synthetic
media containing standard ingredients and 2% glucose
(SD medium), 2% raffinose (SR medium), or 2% raffi-
nose + 2% galactose (SRG medium). The synthetic genetic
array (SGA) compatible S288c strain Y8835 (MAT
ura3::natR can1::STE2pr-Sp_his5 lyp1 his3 1 leu2 0 met15 0)
and isogenic rad23Δ dsk2Δ  (rad23::kanMX dsk2::natR)
cells were used for all assays involving the deletions of
RAD23 and DSK2. Strains JD52 (Mata lys2 ura3 trp1 his3
leu2), JD55 (UBR1::HIS3 in JD52 background) and ufd1-
1  were obtained from Dr. Alex Varshavsky (California
Institute of Technology) [24]. Haploid strains bearing
rad23Δ,  dsk2Δ,  ddi1Δ, rpn10Δ, rpn13Δ, kre22Δ, in the
BY4741 background were obtained from Open Biosys-
tems (Huntsville, AL, USA).
For the Synthetic Dosage Lethality (SDL) screens, hap-
loids were selected on synthetic dextrose medium (2%
glucose; 1.7 g/L yeast nitrogen base w/o ammonium sul-
fate and amino acids; 1 g/L monosodium glutamic acid; 2
g/L amino acid dropout mix lacking uracil, arginine,
lysine and histidine), supplemented with the following
antibiotics 100 mg/L clonNAT (Werner BioAgents Jena
Germany), 200 mg/L geneticin (Invitrogen, Carlsbad, CA,
USA), 50 mg/L L-canavanine (Sigma, St. Louis, MO, USA)
and 50 mg/L S-(2-Aminoethyl)-L-cysteine hydrochloride
(Sigma).
The plasmids expressing the proteasomal substrates Arg-
βgal, Scc1, or UbV76-V-βgal, Ricin A chain (RTA) have been
previously described [24-26] and substrate expression are
regulated by the GAL1  promoter. The pEGH plasmids,
which contain an individual yeast gene tagged with both
Glutathione S-transferase (GST) protein and His6 at its
amino-terminus, were previously described [27,28]. The
movable ORF (MORF) clones were purchased from Open
Biosystems (Huntsville, AL, USA). The plasmid expressing
Ha-Ub was obtained from Dr. Mary Ann Osley (Univer-
sity of New Mexico, Albuquerque, NM, USA).
Genome-wide synthetic dosage lethal screen
The URA3-marked overexpression library and the screen-
ing procedures used in this study were previously
described [28]. Briefly, two isogenic synthetic genetic
array (SGA)-compatible strains, Y8835 and rad23Δ dsk2Δ,BMC Biology 2009, 7:75 http://www.biomedcentral.com/1741-7007/7/75
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were mated to an ordered yeast array expressing 5200
unique galactose-inducible genes. The arrayed strains
were subjected to diploid selection, sporulation and two
rounds of haploid selection [28-30], to give rise to an out-
put array of duplicated colonies carrying the desirable
natR-marked deletion and one unique galactose-induci-
ble gene. The haploid arrays were finally replica-pinned
onto media containing 2% glucose (uninduced condi-
tion) or 2% galactose (induced gene expression condi-
tion). The colonies on the glucose and galactose plates
were photographed after two and three days of incuba-
tion, respectively. Overexpressed genes that uniquely
caused a reduction in colony size of more than 20% in the
rad23Δ dsk2Δ  background were considered for down-
stream analysis.
Expression shut-off assay and proteasome inhibition 
treatment
Yeast cells carrying plasmids expressing hexahistidine
(His6) and GST double-tagged proteins from the GAL1
promoter were grown at 30°C to an OD600 of approxi-
mately 1 in SR-ura medium with auxotrophic supple-
ments and 2% raffinose as the carbon source. Protein
expression was induced with 2% galactose for 3 h and
then repressed by the addition of 2% glucose. Cyclohex-
imide (100 μg/ml) was also added to stop translation.
Samples were withdrawn at the indicated time points and
harvested by centrifugation. Proteins were extracted by
glass bead lysis of cells, processed for immunoprecipita-
tion with Glutathione sepharose beads (GE-Healthcare,
Piscataway, NJ, USA), and resolved by 10% SDS-PAGE.
Immunoblots were probed with anti-His6 antibody
(Abcam, Cambridge, UK) followed by detection with goat
anti-mouse Horseradish Peroxidase (HRP) conjugate
using Chemiluminescent reagents (GE-Healthcare). The
stable protein Rpt5 was used as a loading control in the
expression shutoff experiments.
Proteasome inhibition was performed as described [31].
Briefly, yeast cells were grown in synthetic media using
proline as the only nitrogen source. SDS (0.003%) was
added to the media 3 h before galactose induction.
MG132 (75 μM; Biomol) was added 30 min before the
addition of glucose. Samples were collected at indicated
time points and processed as described above.
Detection of ubiquitylated substrates
Yeast cells expressing GST-tagged substrates and Ha-
tagged Ub or myc-tagged Ub were grown in galactose-con-
taining SG medium to an OD600 of approximately 1. Cells
were lysed with glass beads and immunoprecipitated with
Glutathione sepharose beads for 2 h at 4°C. The immuno-
precipitates were resolved by SDS-PAGE, transferred to
Polyvinylidene fluoride (PVDF) membrane, and immu-
noblotted with anti-Ha antibody (Covance, Berkeley, CA,
USA), followed by anti-mouse HRP conjugates and ECL
reagents.
Results
Accumulation of proteasomal substrates in degradation 
mutants can lead to growth retardation
We set out to look for physiological substrates of Rad23
and Dsk2. Many strategies have been developed in the
past to isolate the substrates of a particular Ub/proteas-
ome pathway with varying degrees of success. Most of
these methods explore the facts that substrates directly
bind to the degradation machinery and/or substrates are
ubiquitylated. Two challenges often encountered in these
endeavors are the transient nature of the interaction
between substrates and degradation components, and
low levels of substrate expression in vivo.
To identify the physiological functions of Rad23 and
Dsk2, we employed a synthetic dosage lethality screen
[32,33]. The premise of SDL is that increased levels of a
protein have little toxic effect on the growth of a wild-type
strain but may cause growth retardation or even lethality
in a mutant strain. Previous studies suggest that this strat-
egy can be adapted to isolate substrates of the Ub/protea-
some system. For example, overexpression of several cell
cycle proteins (e.g., Clb2, Sic1, Scc1) in proteolysis-defi-
cient cells (e.g. apc mutant, cdc34 mutant, ubr1 mutant)
led to extremely slow cell growth (Figure 1A and refer-
ences [24,34,35]). The growth defect induced by substrate
Scc1 overexpression is particularly striking in the case of
ubr1Δ cells lacking the E3 enzyme of the N-end rule deg-
radation pathway, since the absence of UBR1 alone does
not significantly alter cell growth [36].
We then wondered whether the toxicity might be related
to the physiological functions of the substrates. In other
words, would accumulation of large amounts of any sub-
strate lead to growth retardation in proteolysis-deficient
cells? We used an artificially designed N-end rule substrate
Arg-βgal, which contains βgalactosidase from E. coli fused
to a destabilizing residue Arg [37]. Deletion of UBR1 leads
to the accumulation of Arg-βgal, which does not affect cell
growth (Figure 1A). Similarly, we found that compro-
mised degradation of another model substrate of the pro-
teasome UbV76-Val-βgal does not elicit toxicity in rad23Δ
dsk2Δ mutants (Figure 1B) [12], indicating that the toxic-
ity triggered by substrate accumulation may depend on
the physiological function of the target protein. These
results further suggest that the SDL screen can identify a
subset of substrates of a given proteolytic pathway.
Identification of yeast genes which cause slower growth in 
rad23 dsk2 mutant cells upon overexpression
The genome-wide SDL screen was carried out as previ-
ously described [28]. More than 5000 yeast genes fused toBMC Biology 2009, 7:75 http://www.biomedcentral.com/1741-7007/7/75
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both glutathione S-transferase and His6 tags were sepa-
rately introduced into wild-type or rad23Δ dsk2Δ mutant
cells [28,29]. We compared the growth of wild type vs.
rad23Δ dsk2Δ cells that expressed each of these yeast genes
from a strong, regulatable GAL1 promoter. The expression
of these genes was repressed in glucose containing media,
but induced in galactose-containing media. Haploids car-
rying these plasmids were pinned onto both SD (glucose
media) and SG (galactose media) plates. Following incu-
bation for two to three days at 30°C (Figure 2A), the col-
ony sizes of these plates were scored using a program
developed in Dr. Boone's Lab (University of Toronto,
Ontario, Canada). Upon their overexpression, a total of
41 genes were found to preferentially cause slower growth
in rad23Δ dsk2Δ mutant cells. Sic1 and Far1, two known
substrates of Rad23 and Dsk2 [7], were not isolated as
positives in our screen because their overexpression leads
to severe toxicity even in wild-type cells (data not shown),
suggesting that genes, which severely reduce growth rate
in wild-type cells may not be recovered in this type of SDL
screen.
As is common in nearly all screens, we expected our
approach to yield false positives, especially since a low
cut-off (20% difference in colony size) is used to define a
hit. The 20% cut-off ensures that most of the toxic genes
are efficiently captured in our screens (Figure 2A). To
eliminate false hits, we performed a serial spotting assay
with each candidate identified. More specifically, wild-
type or rad23Δ dsk2Δ mutant cells containing the candi-
date open reading frame (ORF) regulated by the GAL1
promoter were grown in non-inducible raffinose media to
a similar OD600, and then spotted onto SD and SG plates
in five-fold serial dilutions. The growth rates of wild-type
and rad23Δ dsk2Δ mutant cells bearing a vector plasmid
are similar under the condition (Figure 2B). Of the 41
genes identified in the primary screen, eleven genes were
confirmed to cause noticeably slower growth in mutant
cells than in wild-type cells upon overexpression (Figure
2B).
Whereas two identified genes (i.e. YLL030C, YLR241W)
have not been functionally characterized, the other nine
Accumulation of some proteasomal substrates leads to slower cell growth Figure 1
Accumulation of some proteasomal substrates leads to slower cell growth. (A) Compromised degradation of Scc1, 
but not Arg-βgal, in ubr1Δ mutant cells causes toxicity. The plasmids bearing the N-end rule substrate Arg-βgal or Scc1 were 
separately introduced into wild-type JD52 or ubr1Δ cells as indicated. The expression of these substrates are regulated by the 
galactose-inducible GAL1 promoter. Exponentially growing yeast cells were spotted onto glucose-containing SD-ura (expres-
sion off) and galactose-containing SG-ura (expression on) media in serial five-fold dilutions. The plates were incubated at 30°C 
for two to four days. The substrates used are labeled on the left of the panel, and the strains are labeled on the right. (B) 
Increased levels of the UFD substrate UbV76-Val-βgal in rad23 dsk2 mutant cells do not affect cell growth. The spotting experi-
ments were performed as in A.
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Scc1
Wt

Wt
ubr1
Wt
ubr1
SD: Expression OFF SG: Expression ON A
BBMC Biology 2009, 7:75 http://www.biomedcentral.com/1741-7007/7/75
Page 5 of 12
(page number not for citation purposes)
genes are involved in a variety of cellular processes (see
the  Saccharomyces  Genome Database yeastgenome.org
and the YPD database http://www.proteome.com/data
bases/index.html). AAD10 encodes an aryl alcohol dehy-
drogenase important for amino acid catabolism. Mss11
and Rfx1 are transcription factors involved in the regula-
tion of invasive growth and in DNA damage responses,
respectively. Ppg1 has protein phosphatase activity and is
involved in glycogen accumulation. Systematic deletion
studies suggest that Kre22 (Ydr433w) is involved in glyco-
gen accumulation [38], mitochondrial distribution and
morphology [39], and is important in resistance to DNA
damaging agents (e.g. hydroxyurea, UV and ionizing radi-
ation) [40]. Vph1 is a subunit of the vacuolar H(+)-
ATPase essential for vacuolar acidification. Ste4 functions
as the β subunit of the G protein that mediates pherom-
one-induced signal transduction. DTR1 encodes the dity-
rosine transporter involved in the maturation of the spore
wall. It is worth noting that overexpression of Spc98, a
component of the spindle pole body [41], causes more
severe growth retardation in rad23Δ dsk2Δ mutant cells
than in wild-type cells (Figure 2B), consistent with previ-
ous findings that suggest a role of Rad23 and Dsk2 in
spindle function [19].
Identification of yeast genes that cause stronger growth retardation in rad23 dsk2 mutant cells than in wild-type cells Figure 2
Identification of yeast genes that cause stronger growth retardation in rad23 dsk2 mutant cells than in wild-
type cells. (A) Representative images from plasmid overexpression screen. Each of approximately 5280 yeast ORFs regulated 
by a galactose inducible Gal1 promoter was transformed separately into wild-type Y8835 and rad23Δ dsk2Δ mutant cells. 
Transformants were grown on media containing either glucose (SD, expression off) or galactose (SG, expression on). Each 
ORF is represented by two spots on the plate to reduce false positives. After two days for SD plates and three days for SG 
plates, colony sizes were scored for possible hits. Boxed spots are YLL030C on each plate. Strains and growth conditions are 
labeled at the bottom of each image. (B) A spotting assay indicates 11 genes cause preferential slow growth in rad23Δ dsk2Δ 
mutant cells. The spotting assay was conducted as described in Figure 1A. The identities of these genes and the corresponding 
strains are listed to the left and right of the panels, respectively.
SD
Expression OFF
SG
Expression ON
Wt

Wt

Wt

Wt

Wt

Wt

Wt

Wt

Wt

Wt

Wt

Vector Vector
SPC98 YNL126W
VPH1 YOR270C
RFX1 YLR176C
N/A YLR241W
MSS11 YMR164C
DTR1 YBR180W
STE4 YOR212W
PPG1 YNR032W
AAD10 YJR155W
KRE22 YDR433W
N/A YLL030C
Gene ORF
B
WT SD WT SG
rad23dsk2 SD rad23dsk2 SG
A
Wt
BMC Biology 2009, 7:75 http://www.biomedcentral.com/1741-7007/7/75
Page 6 of 12
(page number not for citation purposes)
The degradation of Kre22 and YLL030C requires Rad23/
Dsk2
As reasoned above, accumulation of a large amount of
substrates can lead to toxicity in cells defective in proteol-
ysis (Figure 1A). We examined the stability of the proteins
encoded by the eleven isolated genes in wild-type or
mutant cells by an expression shut-off assay. Two pro-
teins, Kre22 and YLL030C are rapidly degraded in wild-
type cells, but significantly stabilized in cells lacking
RAD23 and DSK2 (Figure 3A, B), suggesting that they are
degraded by the Rad23/Dsk2 pathway. Deletion of
RAD23 and DSK2 does not significantly alter the half-life
of the other nine proteins identified by our screen (data
not shown).
Previously, we demonstrated that Rad23 works with two
different co-factors Ufd2 (a Ub chain elongation factor,
E4) and Png1 (a deglycosylation enzyme) to degrade dis-
tinct substrates [20,26]. Here, we examined whether
Kre22 or YLL030C turn-over requires Ufd2 or Png1. Dele-
tion of Ufd2 does not alter the degradation of Kre22 or
YLL030C (Figure 3C, D). The Png1-Rad23 complex is
Kre22 and YLL030C are degraded by a Rad23/Dsk2-dependent pathway Figure 3
Kre22 and YLL030C are degraded by a Rad23/Dsk2-dependent pathway. (A-B) Degradation of Kre22 and YLL030C 
is impaired in cells lacking RAD23 and DSK2. Wild-type (Y8835) and mutant cells containing a GAL1 promoter regulated GST 
and His6 tagged Kre22 or YLL030C were first grown in raffinose-containing media. Protein expression was then induced by 
the addition of galactose. Samples were taken after expression shutoff at intervals, processed for immunoprecipitation with 
GST beads, and analyzed by Western blotting using anti-His6 antibody. Equal amounts of protein extracts were used and con-
firmed by blotting with anti-Rpt5 antibody in all of the expression shutoff experiments (lower panels). (C-D) Degradation of 
Kre22 and YLL030C is Ufd2-independent. The stability of Kre22 or YLL030C in wild-type or ufd2Δ mutant cells was deter-
mined by an expression shut-off assay as described in A. (E) Kre22 and YLL030C are not glycosylated. GST-tagged Kre22 or 
YLL030C was expressed in wild-type cells and recovered by immunoprecipitation. The immunoprecipitates were mock treated 
(-) or digested (+) with Endoglycosidase H (Endo H), resolved by SDS-PAGE, and visualized by immunoblotting. If the proteins 
are N-glycosylated, the bands are expected to migrate faster on the gel after Endo H treatment. A positive control for EndoH 
treatment of RTA is also included on the right [26]. (F-G) Degradation of Kre22 and YLL030C appended with other epitope 
tags is compromised in cells lacking RAD23 and DSK2. The stability of Kre22 or YLL030C tagged with C-terminal Ha epitope 
and the IgG-binding domain from protein A in wild-type and rad23Δ dsk2Δ mutant cells was determined as described in A, 
except the immunoprecipitation was done with IgG sepharose and the blots were probed with anti-Ha antibody.
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involved in degrading glycosylated proteins [26]. We
found that neither protein is glycosylated (Figure 3E), sug-
gesting that Kre22 and YLL030C are not Png1 substrates.
It is likely that these substrates would require co-factors
other than Ufd2 and Png1 for their degradation.
Since these substrates are tagged with GST moiety at their
N-terminus, one concern of our results is that the degrada-
tion of these proteins may be altered by the GST fusion. To
this end, we obtained the MORF plasmids expressing
YLL030C and Kre22, which are tagged at their carboxyl-
terminus with both His6 and the IgG-binding site from
protein A (Open Biosystems) that theoretically could also
affect protein degradation. As shown in Figure 3, YLL030C
and Kre22 are still degraded in Rad23/Dsk2-dependent
manner (Figure 3F, G), suggesting that the involvements
of Rad23 and Dsk2 in Kre22 and YLL030C degradation
are not due to artifacts caused by GST tags. Overexpression
of these MORF plasmids also led to growth retardation in
rad23Δ dsk2Δ mutant cells (data not shown).
Kre22 and YLL030C are ubiquitylated, proteasomal 
substrates
Are these newly identified Rad23/Dsk2 substrates
destroyed by the proteasome or some other proteolytic
activity (e.g. lysosome)? To assess the involvement of the
proteasome in the degradation of Kre22 or YLL030C, we
carried out a simple proteasome inhibition assay [31]. We
found that the degradation of Kre22 or YLL030C is
impaired upon MG132 treatment (Figure 4A, B), suggest-
ing that these proteins are degraded by the proteasome.
Most, but not all, proteasomal substrates are ubiquit-
ylated. The function of Rad23/Dsk2 in proteolysis
requires their UBA domains, which bind to Ub [4]. To
determine whether the newly identified substrates are
ubiquitylated, we co-transformed the plasmid expressing
the GST- and His6-tagged substrate with the plasmid bear-
ing Ha-tagged Ub into wild-type or rad23Δ dsk2Δ mutant
cells. GST-tagged substrates were immunoprecipitated
from cellular lysates with GST beads, and processed for
Western blotting with anti-Ha antibody to detect ubiquit-
Ubiquitin and the proteasome are involved in Kre22 and YLL030C degradation Figure 4
Ubiquitin and the proteasome are involved in Kre22 and YLL030C degradation. (A-B) Kre22 and YLL030C are 
degraded by the proteasome. Wild-type yeast cells expressing Kre22 or YLL030C were treated with or without the proteas-
ome inhibitor MG132. To facilitate the uptake of MG132 by wild-type yeast cells, we used L-proline as the nitrogen source in 
the growth medium and added a small amount of SDS (0.003%). (C) Kre22 and YLL030C are ubiquitylated. GST- and His6-
tagged substrates were co-transformed with Ha-tagged Ub into wild-type or rad23 dsk2 mutant cells. Kre22 or YLL030C was 
precipitated with GST beads and analyzed by immunoblotting first with anti-Ha antibody and later anti-His6 antibody. Ubiquit-
ylated and non-ubiquitylated Kre22 and YLL030C proteins are indicated on two sides of the upper panel. Rpt5 (bottom panel) 
is used as a loading control.
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ylated substrate. We found that both Kre22 and YLL030C
are ubiquitylated (Figure 4C). Consistent with the func-
tion of Rad23 and Dsk2 at a pre-proteasome but post-
ubiquitylation step [4,5], much more ubiquitylated spe-
cies were detected in the rad23Δ dsk2Δ mutants than in
wild type cells (Figure 4C).
The involvement of specific Ub receptor for the 
degradation of Kre22 or YLL030C
Ub-binding proteins that function in proteasome-medi-
ated proteolysis include three UBA/UBL proteins (i.e.
Rad23, Dsk2, Ddi1), two proteasome-associated factors
Rpn10 and Rpn13, and the Ufd1-Cdc48-Npl4 complex
[2,21]. These Ub-receptors have different substrates and
sometimes carry out overlapping functions [2]. We exam-
ined the stability of GST-tagged Kre22 and YLL030C in
yeast cells lacking individual Ub receptor (Figure 5A-H).
Both Dsk2 and Ufd1 are required for efficient degradation
of YLL030C (Figure 5B, D, F, H). Interestingly, Dsk2 is the
only Ub receptor involved in Kre22 degradation (Figure
5A, C, E, G). Furthermore, consistent with the restriction
of Dsk2 by Rpn10 [42], Kre22 and YLL030C are degraded
faster in rpn10Δ cells than in wild-type cells (Figure 5C,
D).
Kre22 overexpression suppresses Dsk2-induced toxicity
To our knowledge, Kre22 is the first substrate that requires
only Dsk2 but none of the other Ub receptors for its deg-
radation (Figure 5A, C, E, G). Supporting the direct link
between Dsk2 and Kre22, we detected the Dsk2-Kre22
interaction by co-immunoprecipitations (Figure 6A). It
will be important to determine the specific domains of
Dsk2 involved in Kre22-binding and degradation, and the
role of ubiquitylation in the Dsk2-Kre22 interaction.
Since little is known about Dsk2-specific substrates, we
examined the Ub linkage assembled onto Kre22. Lys48-
and Lys63-linked chains were recently linked to the Dsk2
pathway [42]. Specifically, we employed Ub mutants (i.e.
Lys48Arg, Lys63Arg) that had either Lys48 or Lys63
replaced with Arg, which in turn blocked Ub conjugation
to these lysine residues [2,3,6]. We found that Kre22 ubiq-
uitylation was abolished by Lys48Arg mutation (Figure
Kre22 and YLL030C degradation in yeast cells lacking individual Ub receptor Figure 5
Kre22 and YLL030C degradation in yeast cells lacking individual Ub receptor. (A-H) Degradation of GST-tagged 
Kre22 and YLL030C in cells lacking RAD23, DSK2, DDI1, RPN10, RPN13, UFD1 was determined as described in Figure 3A.
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6B), suggesting that the Ub chain attached to Kre22 con-
tained Lys48 linkage.
Among Ub-binding proteins involved in proteasome-
mediated proteolysis, Dsk2 has the unique property that
its overexpression caused toxicity [19,42]. We examined
whether the deletion or overexpression of Kre22 could
counteract overdose of Dsk2 (Figure 6C, D). Interestingly,
increased expression of Kre22 partially suppressed Dsk2-
induced toxicity (Figure 6D). We then asked whether
other proteasomal substrates could keep Dsk2 in check.
We employed RTA, a Rad23, but not Dsk2 substrate, and
UbV76-Val-βgal that is regulated by both Rad23 and Dsk2.
Interestingly, the suppression of Dsk2 is substrate specific
The interactions between Kre22 and Dsk2 Figure 6
The interactions between Kre22 and Dsk2. (A) Kre22 binds Dsk2. Co-immunoprecipitation analysis of the interaction 
between GST-His6-tagged Kre22 and Dsk2-TAP was done as previously described [20]. Briefly, proteins were extracted from 
cells expressing endogenous Dsk2-TAP and galactose-inducible GST-His6-tagged Kre22 and immunoprecipitated with either 
IgG or GST-beads as indicated on the left. Immunoprecipitates were resolved by SDS-PAGE and probed with indicated anti-
bodies. The identity of the bands is indicated on the right. The antibodies for IP and immuno-blot (IB) are shown to the left of 
the panels. (B) Kre22 ubiquitylation involves Lys48-linked Ub chains. GST-His6-tagged Kre22 was co-transformed with myc-
tagged wild-type or mutant Ub into wild-type cells. Kre22 was precipitated with GST beads and analyzed by immunoblotting 
first with anti-myc antibody and later anti-His6 antibody. Ubiquitylated and non-ubiquitylated Kre22 proteins are indicated on 
the left of the panels. (C) The deletion of KRE22 does not alter DSK2-induced toxicity. The spotting assay was done as 
described in Figure 1A. The vector plasmid or plasmid bearing DSK2 regulated by the galactose-inducible GAL1 promoter was 
separately introduced into wild-type or kre22Δ cells as indicated. Exponentially growing yeast cells were spotted onto glucose-
containing SD-ura (expression off) and galactose-containing SG-ura (expression on) media in serial five-fold dilutions. The 
strains used and the plasmid for DSK2 overexpression are labeled on the left of the panels. (D) overexpression of KRE22, but 
not two other proteasomal substrates RTA and UbV76-V-βgal, suppressed DSK2-trigged slow growth in wild-type cells. The 
spotting assay was done as described above. The expression of these substrates is also regulated by the GAL1 promoter. The 
identities of these substrates and the plasmid for DSK2 overexpression are listed to the left of the panels.
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since the overexpression of RTA or UbV76-Val-βgal could
not overcome Dsk2-triggered toxicity (Figure 6D).
YLL030C overexpression also partially suppressed Dsk2-
induced growth retardation (data not shown)
Discussion
We describe herein the use of a large-scale SDL screen as a
new approach to identify proteolytic targets of the Rad23/
Dsk2-dependent pathway. Although many strategies have
been developed for substrate isolation, the identification
of physiological targets of proteolytic pathways has
proven to be quite challenging. For example, the first
genetically defined Ub-dependent proteolytic pathway
(i.e. N-end rule) was discovered in the mid-1980s [37,43].
Despite over a decade of intense efforts, the first cellular
substrate of the N-end rule pathway was identified fortui-
tously. A key cell cycle protein, Scc1 is cleaved at the met-
aphase-anaphase transition [44] and the resulting
carboxyl-terminal fragment is destroyed by the N-end rule
pathway to maintain chromosome stability [24]. Interest-
ingly, overexpression of Scc1 leads to lethality in mutant
cells lacking the N-end rule E3 enzyme (Figure 1A, and
reference [24]). This finding highlights the difficulty in
obtaining proteolytic substrates and also suggests that an
SDL screen could be effective for substrate identification.
An SDL approach was first employed to uncover genetic
interactions in DNA replication or chromosome segrega-
tion [32,33]. More recently, it was demonstrated that SDL
screens could be used to identify novel targets of a protein
kinase (i.e. Pho85) [28]. Our study further extends the
effectiveness of the SDL screen to the Ub/proteasome sys-
tem. The advantages of SDL as a screening tool for prote-
olytic substrate identification include that the assay is
performed in vivo, and the protein expression levels are
enhanced by the strong promoter (i.e. GAL1). Like other
approaches for target discovery, SDL screens have limita-
tions. Of approximately 5000 yeast genes we screened,
only two Dsk2 substrates were isolated. Several factors
may contribute to the high false negative level: 1) redun-
dancy of various substrate delivery pathways [7,8,23]. Sev-
eral known Dsk2/Rad23 substrates (e.g. Sic1) [7,8,23]
were not recovered in this screen. In the absence of Dsk2/
Rad23, other Ub adaptor molecules (e.g. Rpn10, Cdc48,
Ddi1, Rpn13) may maintain sufficient proteolysis [7,8];
2) genes that lead to severe growth defects in wild-type
cells with increased dosage are likely to be excluded from
such analysis; 3) not all substrates would elicit enhanced
fitness defects in proteolysis mutants (Figure 1); 4) the
screen is an indirect way for target discovery. Large
number of false positives, partly due to a low colony size
cutoff, may mask some true positives; 5) screening strat-
egy and criteria for target identification may need further
refinement. For example, the rapid turnover or absence of
particular substrates might be a requirement under very
specific environmental or physiological conditions,
which were not covered by our standardized screening
protocol (e.g. degradation of nuclear-specific Far1 in
response to mating pheromone). Nevertheless, given the
difficulty involved in substrate isolation, we believe that
SDL provides another way to delineate the functional rela-
tionship between a substrate and the specific degradation
pathway.
To our knowledge, GST-Kre22 is the first substrate that
requires only Dsk2, but not other Ub receptors (e.g.
Rpn10, Rad23) for degradation (Figure 5A, C, E, G). Inter-
estingly, overexpressed Kre22 but not other proteasomal
substrates suppresses Dsk2-induced toxicity (Figure 6D).
Although the precise mechanism underlying the Dsk2-
triggered toxic effect is not clear [42], one possible expla-
nation is that excessive Dsk2 may engage in the abnormal
activities that interfere with cell growth. And increased
amount of specific substrates may keep Dsk2 in check.
Our results suggest that Kre22 could serve as an important
tool to understand the Dsk2-dependent proteolysis.
Most proteins identified are not direct proteolytic sub-
strates of Rad23 and Dsk2. This is not unexpected since
other genes that function in the linear pathway of Rad23/
Dsk2 target may also induce toxicity in rad23 dsk2 mutant
cells upon their overexpression. For example, in a separate
study on the function of Rad23 and Dsk2, we identified a
cell cycle protein involved in the spindle pole body (SPB)
duplication as a degradation target of Rad23 and Dsk2
(C.L., H.R., unpublished results). Interestingly, this pro-
tein is known to act upstream of Spc98, a component of
the SPB [41]. It is likely that increased levels of Spc98
mimic the accumulation of this Rad23/Dsk2 target
involved in spindle regulation to affect SPB duplication,
which in turn triggers growth retardation in rad23 dsk2
mutant cells. Therefore, although the other eight proteins
identified by our screen are not regulated directly by
Rad23 and Dsk2, we suspect that these proteins work with
Rad23/Dsk2 targets in vivo and cellular responses to their
overexpression require the function of Rad23 and Dsk2
(Figure 2B).
Conclusion
In conclusion, as proof-of-concept, we show that an SDL
screen offers an effective, complementary method to elu-
cidating biological functions of proteolytic pathways.
Dsk2 was first identified 11 years ago in a genetic screen
for genes involved in SPB duplication [19]. To our knowl-
edge, the Spc98-induced toxicity in rad23 dsk2 mutant
cells is the second piece of evidence linking Dsk2 and
Rad23 to SPB duplication, which will help us to unravel
the specific role of Rad23 and Dsk2 in this process. It is
also conceivable that the SDL screen can be adapted to
identify relevant ubiquitylation enzymes involved in sub-BMC Biology 2009, 7:75 http://www.biomedcentral.com/1741-7007/7/75
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strate turnover. The creation of RNAi knock-down librar-
ies and ORF overexpression collections would extend the
use of SDL screens in the Ub/proteasome system to higher
eukaryotes.
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